Skip to content

Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)

Clinical Evaluation of a Modified Light Transmission IOL

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00747227
Enrollment
250
Registered
2008-09-05
Start date
2006-12-31
Completion date
2009-06-30
Last updated
2011-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

cataract, monofocal, intraocular lens, acrylic

Brief summary

The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).

Detailed description

The investigational IOL will be found to be safe and effective with respect to visual acuity, color vision, contrast sensitivity and complications and will be similar to results for the ZA9003 control eyes. Complication rates and adverse event rates will be within the FDA grid for posterior chamber IOLs.

Interventions

DEVICEmodified light transmission intraocular lens

violet visible light blocking acrylic intraocular lens

DEVICEmonofocal acrylic intraocular lens

conventional hydrophobic acrylic intraocular lens

Sponsors

Abbott Medical Optics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years of age or older * Bilateral cataracts for which phacoemulsification extraction and posterior IOL implantation has been planned * Visual potential in both eyes of 20/30 Snellen or better after cataract removal and IOL implantation * Preoperative corneal astigmatism of 1.5 diopters or less

Exclusion criteria

* Use of systemic or ocular medications that may affect vision * Uncontrolled systemic or recurrent ocular disease * Requiring an intraocular lens \<15.0 or \>26.0 diopters * Abnormal results with the Farnsworth-Munsell D-15 and/or Ishihara color plates * History of ocular trauma or prior ocular surgery * Known pathology that may affect visual acuity or visual field * Corneal abnormalities * Pupil abnormalities * Capsule or zonular abnormalities

Design outcomes

Primary

MeasureTime frameDescription
Best Corrected Distance Visual AcuityOne yearSnellen Equivalent visual acuity of 20/40 or better
Uncorrected Distance Visual AcuityOne YearSnellen Equivalent of 20/40 or better at one year

Secondary

MeasureTime frameDescription
Contrast Sensitivity4-6 monthsContrast sensitivity is the measurement of how faded an image may become before it can clearly be seen. Contrast sensitivity was measured in photopic and mesopic conditions at the following spatial frequencies: 3.0, 6.0, 12.0, and 18 cpd (cycles per degree). Contrast sensitivity is measured in log units. A higher value for the logarithmic units translates to better contrast sensitivity.
Subject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as Good or Excellent.One YearSubjects indicating a subjective response to a multiple choice question, At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind?, on a multi-item questionnaire administered by interviewer to determine subject satisfaction with their overall visual outcome at the one year visit.

Countries

United States

Participant flow

Recruitment details

250 subjects from normal cataract populations who were undergoing primary phacoemulsification with lens implantation and did not have any other visually significant ocular pathologies were selected at 12 investigation sites across the country

Participants by arm

ArmCount
ZV9003 Intraocular Lens
modified light transmission intraocular lens
126
ZA9003 Intraocular Lens
monofocal acrylic intraocular lens
124
Total250

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath31
Overall StudyIllness11
Overall StudyLost to Follow-up12
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicZV9003 Intraocular LensZA9003 Intraocular LensTotal
Age Continuous73.3 years
STANDARD_DEVIATION 8
71.5 years
STANDARD_DEVIATION 8
72.4 years
STANDARD_DEVIATION 8
Age, Customized
<60 years
4 participants8 participants12 participants
Age, Customized
>=80
30 participants21 participants51 participants
Age, Customized
Between 60 and 69 years
35 participants41 participants76 participants
Age, Customized
Between 70 and 79 years
57 participants54 participants111 participants
Region of Enrollment
United States
126 participants124 participants250 participants
Sex: Female, Male
Female
78 Participants68 Participants146 Participants
Sex: Female, Male
Male
48 Participants56 Participants104 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1260 / 124
serious
Total, serious adverse events
1 / 1261 / 124

Outcome results

Primary

Best Corrected Distance Visual Acuity

Snellen Equivalent visual acuity of 20/40 or better

Time frame: One year

Population: One subject was excluded from the analysis because the ZV9003 lens was implanted in the first eye and the ZA900 lens was implanted in the second eye. All subjects in the outcomes analysis had the same lens in both eyes.

ArmMeasureValue (NUMBER)
ZV9003 Intraocular LensBest Corrected Distance Visual Acuity119 participants
ZA9003 Intraocular LensBest Corrected Distance Visual Acuity120 participants
Primary

Uncorrected Distance Visual Acuity

Snellen Equivalent of 20/40 or better at one year

Time frame: One Year

Population: One subject was excluded from the analysis because the ZV9003 lens was implanted in the first eye and the ZA900 lens was implanted in the second eye. All subjects in the outcomes analysis had the same lens in both eyes.

ArmMeasureValue (NUMBER)
ZV9003 Intraocular LensUncorrected Distance Visual Acuity110 participants
ZA9003 Intraocular LensUncorrected Distance Visual Acuity116 participants
Secondary

Contrast Sensitivity

Contrast sensitivity is the measurement of how faded an image may become before it can clearly be seen. Contrast sensitivity was measured in photopic and mesopic conditions at the following spatial frequencies: 3.0, 6.0, 12.0, and 18 cpd (cycles per degree). Contrast sensitivity is measured in log units. A higher value for the logarithmic units translates to better contrast sensitivity.

Time frame: 4-6 months

Population: Binocular contrast sensitivity testing was reported for all binocular subjects with data available at the 4-6 month visit on 120 subjects in each group. One ZA9003 subject was tested at 3.0 cpd and not tested for 6.0 cpd through 18.0 cpd (mesopic and photopic). Testing for levels 6.0 through 18.0 were not reported.

ArmMeasureGroupValue (MEAN)
ZV9003 Intraocular LensContrast SensitivityMesopic condition at 3.0 cpd1.62 log contrast
ZV9003 Intraocular LensContrast SensitivityMesopic condition at 6.0 cpd1.65 log contrast
ZV9003 Intraocular LensContrast SensitivityMesopic condition at 12.0 cpd1.14 log contrast
ZV9003 Intraocular LensContrast SensitivityMesopic condition at 18.0 cpd0.60 log contrast
ZV9003 Intraocular LensContrast SensitivityPhotopic condition at 3.0 cpd1.76 log contrast
ZV9003 Intraocular LensContrast SensitivityPhotopic condition at 6.0 cpd1.91 log contrast
ZV9003 Intraocular LensContrast SensitivityPhotopic condition at 12.0 cpd1.58 log contrast
ZV9003 Intraocular LensContrast SensitivityPhotopic condition at 18.0 cpd1.09 log contrast
ZA9003 Intraocular LensContrast SensitivityPhotopic condition at 18.0 cpd1.14 log contrast
ZA9003 Intraocular LensContrast SensitivityMesopic condition at 3.0 cpd1.62 log contrast
ZA9003 Intraocular LensContrast SensitivityPhotopic condition at 3.0 cpd1.74 log contrast
ZA9003 Intraocular LensContrast SensitivityMesopic condition at 6.0 cpd1.63 log contrast
ZA9003 Intraocular LensContrast SensitivityPhotopic condition at 12.0 cpd1.59 log contrast
ZA9003 Intraocular LensContrast SensitivityMesopic condition at 12.0 cpd1.17 log contrast
ZA9003 Intraocular LensContrast SensitivityPhotopic condition at 6.0 cpd1.94 log contrast
ZA9003 Intraocular LensContrast SensitivityMesopic condition at 18.0 cpd0.65 log contrast
Secondary

Subject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as Good or Excellent.

Subjects indicating a subjective response to a multiple choice question, At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind?, on a multi-item questionnaire administered by interviewer to determine subject satisfaction with their overall visual outcome at the one year visit.

Time frame: One Year

Population: Two subjects in the ZV9003 group did not complete the one year questionnaire.

ArmMeasureValue (NUMBER)
ZV9003 Intraocular LensSubject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as Good or Excellent.112 participants
ZA9003 Intraocular LensSubject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as Good or Excellent.113 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026